Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
(PubMed) Zuin M, Cervellati C, Brombo G, Trentini A, Roncon L, Zuliani G
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis
[68] [45] Ligands [edit] Agonists [edit] Mixed [edit] Antagonists [edit] Steroidal antiandrogens (e.g., cyproterone acetate, chlormadinone acetate, spironolactone, oxendolone) Nonsteroidal antiandrogens (e.g., flutamide, nilutamide, bicalutamide, enzalutamide, apalutamide, RU-58841) N-Terminal domain antiandrogens (e.g., bisphenol A, EPI-001, ralaniten, JN compounds) [70] As a drug target [edit] The AR is an important therapeutic target in prostate cancer
It is being studied in models of rheumatoid arthritis, COPD, Crohn's disease, and pulmonary fibrosis.Delgado et al., Pharmacol Rev 2004)
US$ 23.21
US$ 21.95
US$ 26.96
US$ 21.03
